Literature DB >> 21145892

Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse.

Wendy W Yang1, Richard L Sidman, Tatyana V Taksir, Christopher M Treleaven, Jonathan A Fidler, Seng H Cheng, James C Dodge, Lamya S Shihabuddin.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. However, recent reports suggest an active role of non-neuronal cells in the pathogenesis of the disease. Here, we examined quantitatively the temporal development of neuropathologic features in the brain and spinal cord of a mouse model of ALS (SOD1(G93A)). Four phases of the disease were studied in both male and female SOD1(G93A) mice: presymptomatic (PRE-SYM), symptomatic (SYM), endstage (ES) and moribund (MB). Compared to their control littermates, SOD1(G93A) mice showed an increase in astrogliosis in the motor cortex, spinal cord and motor trigeminal nucleus in the SYM phase that worsened progressively in ES and MB animals. Associated with this increase in astrogliosis was a concomitant increase in motor neuron cell death in the spinal cord and motor trigeminal nucleus in both ES and MB mice, as well as in the ventrolateral thalamus in MB animals. In contrast, microglial activation was significantly increased in all the same regions but only when the mice were in the MB phase. These results suggest that astrogliosis preceded or occurred concurrently with neuronal degeneration whereas prominent microgliosis was evident later (MB stage), after significant motor neuron degeneration had occurred. Hence, our findings support a role for astrocytes in modulating the progression of non-cell autonomous degeneration of motor neurons, with microglia playing a role in clearing degenerating neurons. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145892     DOI: 10.1016/j.expneurol.2010.11.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

1.  Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Hongxia Lei; Elisabeth Dirren; Carole Poitry-Yamate; Bernard L Schneider; Rolf Gruetter; Patrick Aebischer
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-05       Impact factor: 6.200

2.  Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone.

Authors:  Jonathan A Fidler; Christopher M Treleaven; Ashley Frakes; Thomas J Tamsett; Mary McCrate; Seng H Cheng; Lamya S Shihabuddin; Brian K Kaspar; James C Dodge
Journal:  FASEB J       Date:  2011-08-29       Impact factor: 5.191

3.  Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.

Authors:  Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2015-06-22       Impact factor: 3.215

4.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

Review 5.  Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodents.

Authors:  Deepa B Rao; Peter B Little; Robert C Sills
Journal:  Toxicol Pathol       Date:  2013-10-16       Impact factor: 1.902

Review 6.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

7.  Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.

Authors:  Katherine E Lewis; Anna L Rasmussen; William Bennett; Anna King; Adrian K West; Roger S Chung; Meng Inn Chuah
Journal:  J Neuroinflammation       Date:  2014-03-23       Impact factor: 8.322

Review 8.  Microglia centered pathogenesis in ALS: insights in cell interconnectivity.

Authors:  Dora Brites; Ana R Vaz
Journal:  Front Cell Neurosci       Date:  2014-05-22       Impact factor: 5.505

9.  Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  David J Gifondorwa; Ramon Jimenz-Moreno; Crystal D Hayes; Hesam Rouhani; Mac B Robinson; Jane L Strupe; James Caress; Carol Milligan
Journal:  Neurol Res Int       Date:  2012-08-01

10.  The Role of the Innate Immune System in ALS.

Authors:  Sudarshan Phani; Diane Berengere Re; Serge Przedborski
Journal:  Front Pharmacol       Date:  2012-08-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.